Hyperion Therapeutics Inc (NASDAQ:HPTX)

Data as of Jan 30
 -0.73 / -2.80%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Hyperion Therapeutics, Inc. is a biopharmaceutical company, which focuses on the development and commercialization of novel therapeutics to treat disorders in orphan diseases and hepatology. Its product, Ravicti is designed to lower ammonia in blood and for the treatment of urea cycle disorders and hepatic encephalopathy. The company was founded by Mark Blumling and Chris E. Rivera on November 1, 2006 and is headquartered in Brisbane, CA.

Contact Information

Hyperion Therapeutics, Inc.
2000 Sierra Point Parkway
Brisbane California 94005
P:(650) 745-7802
Investor Relations:
(650) 745-7829



Individual stakeholders49.95%
Mutual fund holders30.50%
Other institutional23.20%

Top Executives

Donald J. SantelPresident, Chief Executive Officer & Director
Jeffrey S. FarrowChief Financial Officer & Senior Vice President
Bruce F. ScharschmidtChief Medical Officer & Senior Vice President
Dion F. CoakleyGlobal Vice President-Clinical Operations
Christine A. NashChief Commercial Officer & Senior Vice President

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.